Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fumihiro Ogawa and Ryo Saji.
Fumihiro Ogawa
Connection Strength
0.537
Ryo Saji
  1. Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19. Thromb J. 2021 Aug 16; 19(1):55.
    View in: PubMed
    Score: 0.241
  2. Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19. PLoS One. 2021; 16(8):e0256022.
    View in: PubMed
    Score: 0.240
  3. Serum cholinesterase associated with COVID-19 pneumonia severity and mortality. J Infect. 2021 02; 82(2):282-327.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.